04/21/2025 3:23 PM | Apellis Pharmaceuticals (Issuer) WHEELER CRAIG A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 6:11 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2025 11:27 AM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 2:18 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025 6:22 AM | Apellis Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025 6:00 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2025 12:59 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2025 2:13 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025 9:49 AM | Apellis Pharmaceuticals (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025 12:09 PM | Apellis Pharmaceuticals (Subject) MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/30/2025 11:13 AM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for APLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
01/30/2025 11:15 AM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:18 AM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:20 AM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:01 AM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:03 AM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:07 AM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:10 AM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 11:12 AM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 2:42 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:18 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:22 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:26 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:11 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:12 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:16 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:16 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 2:17 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025 2:37 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:39 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:41 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:23 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:25 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:26 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:28 PM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:29 PM | Apellis Pharmaceuticals (Issuer) Lewis Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:31 PM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 2:19 PM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 3:00 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:39 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:42 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
01/22/2025 2:43 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:44 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:45 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:45 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:51 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:52 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 2:56 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025 2:56 PM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 2:59 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 2:54 PM | Apellis Pharmaceuticals (Issuer) Baumal Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2025 3:38 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025 3:20 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025 3:27 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025 3:29 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025 3:22 PM | Apellis Pharmaceuticals (Issuer) Nicholson Nur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:25 PM | Apellis Pharmaceuticals (Issuer) Sullivan Timothy Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:29 PM | Apellis Pharmaceuticals (Issuer) Townsend Adam J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:30 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:09 PM | Apellis Pharmaceuticals (Issuer) Chopas James George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:10 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:14 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:15 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:55 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 4:56 PM | Apellis Pharmaceuticals (Subject) DeLong Mark Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:00 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:02 PM | Apellis Pharmaceuticals (Subject) Francois Cedric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:02 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:05 PM | Apellis Pharmaceuticals (Subject) Nicholson Nur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:07 PM | Apellis Pharmaceuticals (Subject) Eisele Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:09 PM | Apellis Pharmaceuticals (Subject) Townsend Adam J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:13 PM | Apellis Pharmaceuticals (Subject) Sullivan Timothy Eugene (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 5:15 PM | Apellis Pharmaceuticals (Subject) Lewis Karen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 8:08 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 4:38 PM | Apellis Pharmaceuticals (Issuer) Walbert Keli (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/10/2025 4:39 PM | Apellis Pharmaceuticals (Issuer) Walbert Keli (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 3:03 PM | Apellis Pharmaceuticals (Issuer) Baumal Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 2:17 PM | Apellis Pharmaceuticals (Subject) Baumal Caroline (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024 3:06 PM | Apellis Pharmaceuticals (Issuer) Eisele Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2024 3:15 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2024 3:48 PM | Apellis Pharmaceuticals (Subject) Watson David O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024 3:16 PM | Apellis Pharmaceuticals (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/22/2024 7:47 AM | Apellis Pharmaceuticals (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G | |
11/08/2024 4:31 PM | Apellis Pharmaceuticals (Subject) BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/08/2024 9:52 AM | Apellis Pharmaceuticals (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/05/2024 5:57 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024 5:43 PM | Apellis Pharmaceuticals (Issuer) Francois Cedric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 3:15 PM | Apellis Pharmaceuticals (Issuer) Watson David O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2024 3:20 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:21 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 2:22 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Elon Set to Shock the World by May 1st ? (Ad) Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever…
Yes, even bigger than Tesla or SpaceX. Click here now because after May 1st, it could be too late. |
09/03/2024 2:16 PM | Apellis Pharmaceuticals (Subject) Chopas James George (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:13 PM | Apellis Pharmaceuticals (Issuer) DeLong Mark Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 6:06 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 6:02 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024 6:34 PM | Apellis Pharmaceuticals (Issuer) Dunlop A. Sinclair (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:50 PM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 7:09 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 4:15 PM | Apellis Pharmaceuticals (Issuer) Deschatelets Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 4:13 PM | Apellis Pharmaceuticals (Subject) Deschatelets Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |